Subconjunctival Injection of Triamcinolone for the Treatment of Upper Lid Retraction Associated With Thyroid Eye Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jong Mi | - |
dc.contributor.author | Lee, Hwa | - |
dc.contributor.author | Park, Minsoo | - |
dc.contributor.author | Baek, Sehyun | - |
dc.date.accessioned | 2021-09-06T13:53:25Z | - |
dc.date.available | 2021-09-06T13:53:25Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2012-11 | - |
dc.identifier.issn | 1049-2275 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/107088 | - |
dc.description.abstract | Management of retraction of the upper lid during the congestive phase of thyroid eye disease is usually limited to conservative treatment. We evaluated the efficacy of subconjunctival injection of triamcinolone for the treatment of the upper lid retraction associated with thyroid eye disease. Thirty patients (43 eyes, 11 men and 19 women) with the upper lid retraction associated with thyroid eye disease were evaluated between May 2009 and September 2010. A dose of 0.5 mL of triamcinolone acetonide (40 mg/mL) was injected into the subconjunctival space at the upper margin of the tarsus. If the upper lid retraction had not improved or was still severe 2 weeks after the initial injection, then triamcinolone was injected repeatedly at 2-week intervals. Photographs were taken before the injection and at the follow-up visit, and lid parameters including marginal reflex distance 1, interpalpebral fissure height, total palpebral fissure area, the upper nasal palpebral fissure area, and the upper temporal palpebral fissure area were measured. Changes in the lid parameters after the injection were evaluated. The mean number of injections per patient was 2.67, and the mean (SD) follow-up period was 260.97 (91.10) days. All lid parameters improved significantly after the triamcinolone injection (all P's < 0.05). Nineteen of 22 patients in the congestive phase responded to the triamcinolone injection; however, 6 of 8 patients in the fibrotic phase did not respond to the triamcinolone injection. Complications associated with the triamcinolone injection included an increased intraocular pressure (2 patients) and a mild ptosis (1 patient). The subconjunctival triamcinolone injection is a simple and effective treatment option for the upper lid retraction associated with thyroid eye disease, and this treatment is more effective for the patients in the congestive phase. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | GRAVES OPHTHALMOPATHY | - |
dc.subject | LONG-TERM | - |
dc.subject | FOLLOW-UP | - |
dc.subject | ACETONIDE | - |
dc.subject | TOXIN | - |
dc.subject | METHYLPREDNISOLONE | - |
dc.subject | TISSUE | - |
dc.title | Subconjunctival Injection of Triamcinolone for the Treatment of Upper Lid Retraction Associated With Thyroid Eye Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Baek, Sehyun | - |
dc.identifier.doi | 10.1097/SCS.0b013e3182646043 | - |
dc.identifier.scopusid | 2-s2.0-84873318354 | - |
dc.identifier.wosid | 000311889300094 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CRANIOFACIAL SURGERY, v.23, no.6, pp.1755 - 1758 | - |
dc.relation.isPartOf | JOURNAL OF CRANIOFACIAL SURGERY | - |
dc.citation.title | JOURNAL OF CRANIOFACIAL SURGERY | - |
dc.citation.volume | 23 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1755 | - |
dc.citation.endPage | 1758 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | GRAVES OPHTHALMOPATHY | - |
dc.subject.keywordPlus | LONG-TERM | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | ACETONIDE | - |
dc.subject.keywordPlus | TOXIN | - |
dc.subject.keywordPlus | METHYLPREDNISOLONE | - |
dc.subject.keywordPlus | TISSUE | - |
dc.subject.keywordAuthor | Subconjunctival triamcinolone injection | - |
dc.subject.keywordAuthor | thyroid eye disease | - |
dc.subject.keywordAuthor | upper lid retraction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.